TargetMol

Triletide

Product Code:
 
TAR-TP2356
Product Group:
 
Peptides
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP2356-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2356-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Triletide is a thromboxane A2 antagonist agent.
CAS:
62087-96-1
Molecular Weight:
505.57
Purity:
0.98
SMILES:
[C@H](C(N[C@@H](CC1=CN=CN1)C(OC)=O)=O)(NC([C@H](CC2=CC=CC=C2)NC(C)=O)=O)CC3=CC=CC=C3

References

Repossini L. Preliminary human pharmacokinetics of triletide. Pharmatherapeutica. 1985;4(3 Spec No):189-94. PubMed PMID: 4059299. Waucquez JL. Dose-finding clinical assay of triletide in gastric and duodenal ulceration. Pharmatherapeutica. 1985;4(3 Spec No):146-54. PubMed PMID: 4059296. d'Ambrosio G, d'Annabile A. Effects of combined treatment with triletide and cimetidine in gastric and duodenal ulcer patients, and a retrospective comparison with cimetidine alone. Pharmatherapeutica. 1985;4(3 Spec No):171-6. PubMed PMID: 4059298. Trabucchi E, Longoni F, Baratti C, Boccasanta P. Clinical evaluation of triletide versus antacids in the treatment of duodenal ulcer out-patients. Pharmatherapeutica. 1985;4(3 Spec No):161-5. PubMed PMID: 4059297.